Diabetes

The Lipid Panel – Diabetes and ASCVD Risk

More Than Just a Script: Treating the Whole Patient

Diabesity

The Lipid Panel – The Care of the Diabetic Patient; the Role of GLP1

Case Study: Role of Sodium-Glucose Cotransporter 2 Inhibitors in Managing Residual Cardiovascular Risk

The following case involves a 58-yearold gentleman with a history of complex cardiovascular disease and several cardiometabolic risk factors as…

The Lipid Panel – Hypertriglyceridemia in Patients with T2DM

Case Study: Type 1 Diabetes, Familial Hypercholesterolemia, and Elevated Lipoprotein(a)

Familial hypercholesterolemia (FH) and type 1 diabetes (T1D) are characterized by significant morbidity and premature mortality. Lipoprotein(a) [Lp(a)], an independent…

S6E11: Managing Lipids and Metabolic Syndrome in Youth: Tips from the Experts

Join host Peter H. Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In…

The Impact of Sodium-Glucose Co-Transporter 2 Inhibitors on Lipid Profile

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are novel, effective oral anti-hyperglycemic medications that inhibit glucose reabsorption in the proximal convoluted tubule…

Case Study: Incident Type 2 Diabetes Mellitus following Statin Initiation in Youth

The association of statin use, and incident type 2 diabetes (T2D) is well established in adults. Similar observations have not…

The Intersection of Diabetes, Obesity, and Dyslipidemia

Introduction/Magnitude of The Problem Diabetes mellitus (DM) is a systemic disease of abnormal carbohydrate metabolism leading to chronic hyperglycemia. It is…

Addressing Medication Adherence in Obesity and Diabetes

Medication Adherence Medication adherence is a vital part of managing a patient’s medication regimen but is often overlooked. Between addressing…

Medical Nutrition Therapy for Pre-Diabetes, Diabetes, and Obesity in Adults

Medical nutrition therapy (MNT) by trained registered dietitian nutritionists (RDN) is an integral part of a multidisciplinary health care team.…

Diabetes and Obesity: Transatlantic Considerations on a Global Public Health Issue

Definitions Obesity is defined as the presence of abnormal or excessive fat accumulation, which increases the risk for conditions with…

Risk Reduction: DECLARE-TIMI 58 Outcomes

Results from multiple trials prompted the Food and Drug Administration’s (FDA) approval of empagliflozin (Jardiance) for reducing cardiovascular (CV) death…